tiprankstipranks
Advertisement
Advertisement

CC Stock Latest News

The Chemours Company Lawsuit: Former CEO Mark Newman Seeks Dismissal of Investor Claims
Class ActionThe Chemours Company Lawsuit: Former CEO Mark Newman Seeks Dismissal of Investor Claims
5d ago
CC
Chemours Earnings Call: Pricing Strength Amid Headwinds
PremiumCompany Announcements
Chemours Earnings Call: Pricing Strength Amid Headwinds
15d ago
CC
Chemours price target lowered to $17 from $19 at Goldman Sachs
PremiumThe Fly
Chemours price target lowered to $17 from $19 at Goldman Sachs
17d ago
CC
Chemours price target lowered to $18 from $26 at BMO Capital
PremiumThe Fly
Chemours price target lowered to $18 from $26 at BMO Capital
17d ago
CC
Chemours price target lowered to $15 from $22 at JPMorgan
PremiumThe Fly
Chemours price target lowered to $15 from $22 at JPMorgan
17d ago
CC
Chemours price target lowered to $18 from $21 at Morgan Stanley
PremiumThe FlyChemours price target lowered to $18 from $21 at Morgan Stanley
24d ago
CC
Chemours price target lowered to $18 from $21 at Morgan Stanley
Premium
The Fly
Chemours price target lowered to $18 from $21 at Morgan Stanley
24d ago
CC
Chemours downgraded to Neutral from Buy at UBS
Premium
The Fly
Chemours downgraded to Neutral from Buy at UBS
24d ago
CC
Chemours price target lowered to $24 from $30 at Truist
PremiumThe Fly
Chemours price target lowered to $24 from $30 at Truist
28d ago
CC
Chemours price target lowered to $22 from $26 at RBC Capital
PremiumThe Fly
Chemours price target lowered to $22 from $26 at RBC Capital
28d ago
CC
Chemours: Hold Rating Reaffirmed as Near-Term Headwinds Balance Risk-Reward, Price Target Maintained at $19
PremiumRatings
Chemours: Hold Rating Reaffirmed as Near-Term Headwinds Balance Risk-Reward, Price Target Maintained at $19
29d ago
CC
Chemours: Cyclical Trough Nearing, Margin Strength Supports Buy Rating with Unchanged $26 Price Target
PremiumRatings
Chemours: Cyclical Trough Nearing, Margin Strength Supports Buy Rating with Unchanged $26 Price Target
29d ago
CC
Chemours price target lowered to $22 from $25 at Mizuho
PremiumThe FlyChemours price target lowered to $22 from $25 at Mizuho
29d ago
CC
Closing Bell Movers: SpaceX slips after first quarterly report as public company
Premium
The Fly
Closing Bell Movers: SpaceX slips after first quarterly report as public company
29d ago
CC
AMD
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
Premium
The Fly
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
29d ago
CC
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
PremiumThe Fly
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
29d ago
CC
Chemours reports Q2 adjusted EPS 42c, consensus 42c
PremiumThe Fly
Chemours reports Q2 adjusted EPS 42c, consensus 42c
29d ago
CC
CC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CC Earnings this Week: How Will it Perform?
1M ago
CC
CC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CC
3M (MMM) and DuPont Hit by New York Lawsuit over ‘Forever Chemicals’ Pollution
PremiumMarket News3M (MMM) and DuPont Hit by New York Lawsuit over ‘Forever Chemicals’ Pollution
2M ago
CC
DD
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
Premium
The Fly
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
2M ago
CC
DD
Chemours price target lowered to $25 from $30 at Mizuho
Premium
The Fly
Chemours price target lowered to $25 from $30 at Mizuho
2M ago
CC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >